ALNY vs SWK · P/E 76, rev $1.29B vs P/E 34, rev $7.81B
Alnylam Pharmaceuticals Inc (ALNY) versus Stanley Black & Decker Inc (SWK) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Stanley Black & Decker Inc (SWK) is a tools & accessories company listed on NYSE.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported SWK revenue for 2026-07-04 was $7.81B. Net income was $410.9M. SWK currently screens at market cap $12.82B and trailing P/E 33.8.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. SWK currently screens at market cap $12.82B and trailing P/E 33.8.
Not investment advice. Open the ALNY and SWK stock pages for the full models.
Not investment advice.